{"id":879,"date":"2026-04-02T16:21:48","date_gmt":"2026-04-02T13:21:48","guid":{"rendered":"https:\/\/reocell.com\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/"},"modified":"2026-04-02T18:12:19","modified_gmt":"2026-04-02T15:12:19","slug":"czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi","status":"publish","type":"post","link":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/","title":{"rendered":"Clinical Outcomes of Stem Cell Therapy in Traumatology and Orthopedics"},"content":{"rendered":"

The Center for Advanced Cell Technologies ReoCell was represented at the scientific and practical conference ASIR 2026 \u201cCurrent Challenges in the Treatment of Complications of Traumatic Injuries\u201d<\/span><\/strong>, held on March 26\u201327 in Lviv.<\/p>\n

More details about the conference<\/strong><\/span><\/a><\/p>\n

During<\/span>\u00a0<\/span>the<\/span>\u00a0<\/span>event<\/span>,\u00a0<\/span>leading<\/span>\u00a0<\/span>specialists<\/span>\u00a0<\/span>of<\/span>\u00a0<\/span>the<\/span>\u00a0<\/span>ReoCell<\/span>\u00a0<\/span>team<\/span>\u00a0<\/span>presented<\/span>\u00a0<\/span>advanced<\/span>\u00a0<\/span>approaches<\/span>\u00a0<\/span>to<\/span>\u00a0<\/span>the<\/span>\u00a0<\/span>application<\/span>\u00a0<\/span>of<\/span>\u00a0<\/span>cell-based<\/span>\u00a0<\/span>technologies<\/span>\u00a0<\/span>in<\/span>\u00a0<\/span>traumatology<\/span>\u00a0<\/span>and<\/span>\u00a0<\/span>orthopedics<\/span>,\u00a0<\/span>as<\/span>\u00a0<\/span>well<\/span>\u00a0<\/span>as<\/span>\u00a0<\/span>clinical<\/span>\u00a0<\/span>outcomes<\/span>\u00a0<\/span>of<\/span>\u00a0<\/span>patient<\/span>\u00a0<\/span>treatment<\/span>\u00a0<\/span>using<\/span>\u00a0<\/span>mesenchymal<\/span>\u00a0<\/span>stem<\/span>\u00a0<\/span>cells<\/span>\u00a0(<\/span>MSCs<\/span>).<\/span><\/span><\/p>\n

In particular, a<\/span>\u00a0scientific presentation was delivered by the Medical Director of\u00a0<\/span>ReoCell<\/span>\u00a0Clinic, orthopedic surgeon and traumatologist, PhD\u00a0<\/span><\/span>Dmytro\u00a0<\/span>Horban<\/span><\/span><\/strong>, titled:\u00a0<\/span><\/span>\u201c<\/span><\/span>Orthobiologics<\/span>\u00a0<\/span>in<\/span>\u00a0<\/span>Modern<\/span>\u00a0<\/span>Surgical<\/span>\u00a0<\/span>Practice<\/span>\u201d<\/span><\/span>\u00a0<\/span><\/strong><\/p>\n

\"\"<\/p>\n

Relevance<\/span>\u00a0<\/span>of<\/span>\u00a0<\/span>Cell<\/span>\u00a0<\/span>Therapy<\/span>\u00a0<\/span>in<\/span>\u00a0<\/span>Orthopedics<\/span><\/span><\/span><\/h2>\n

One of the key messages of the presentation highlighted that degenerative tissue changes are directly associated with chronic inflammation, which progresses with age and leads to a decline in function and quality of life.<\/p>\n

Therefore, regenerative medicine is increasingly considered a promising therapeutic approach for degenerative joint disorders.<\/p>\n

Role<\/span>\u00a0<\/span>of<\/span>\u00a0<\/span>Mesenchymal<\/span>\u00a0<\/span>Stem<\/span>\u00a0<\/span>Cells<\/span>\u00a0(<\/span>MSCs<\/span>)<\/span><\/span><\/h2>\n

The\u00a0presentation\u00a0emphasized\u00a0that\u00a0MSCs\u00a0represent\u00a0a\u00a0key\u00a0tool\u00a0in\u00a0regenerative\u00a0medicine\u00a0due\u00a0to\u00a0their\u00a0ability\u00a0to:<\/span>\u00a0<\/span><\/p>\n

    \n
  • self-renew\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
      \n
    • secrete growth factors (VEGF, HGF, IGF-1) that promote tissue regeneration\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
        \n
      • exert immunomodulatory effects\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
          \n
        • differentiate into bone, cartilage, and adipose tissues\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n

          Importantly, the primary therapeutic effect of MSCs is mediated not only through differentiation but predominantly via\u00a0<\/span>paracrine signaling and regulation of inflammation<\/strong>.<\/span>\u00a0<\/span><\/p>\n

           <\/p>\n

          \"\"<\/h3>\n

          Global<\/span>\u00a0<\/span>Contextand<\/span>\u00a0<\/span>Evidense<\/span>\u00a0<\/span>Base<\/span><\/span><\/span><\/h2>\n

          The presentation also outlined the global development of cell-based therapies:<\/span>\u00a0<\/span><\/p>\n

            \n
          • over\u00a0<\/span>1,500 clinical trials<\/strong> involving MSCs worldwide<\/span><\/li>\n<\/ul>\n
              \n
            • approximately\u00a0<\/span>170,000 scientific publications<\/strong><\/li>\n<\/ul>\n
                \n
              • broad application across multiple fields, including orthopedics, immunology, and inflammatory diseases<\/span><\/li>\n<\/ul>\n

                These data reflect the growing scientific and clinical interest in regenerative medicine and its integration into modern medical practice.<\/span>\u00a0<\/span><\/p>\n

                ReoCell<\/span>\u00a0<\/span>Clinical<\/span>\u00a0<\/span>Experience<\/span><\/span><\/h2>\n

                The<\/span>\u00a0<\/span>presentation<\/span>\u00a0<\/span>included<\/span>\u00a0<\/span>clinical<\/span>\u00a0<\/span>outcomes<\/span>\u00a0<\/span>of<\/span>\u00a0<\/span>patients<\/span>\u00a0<\/span>treated<\/span>\u00a0<\/span>at<\/span>\u00a0<\/span>ReoCell<\/span>\u00a0<\/span>Clinic<\/span>\u00a0<\/span>using<\/span> MSC-<\/span>based<\/span>\u00a0<\/span>therapy<\/span>,\u00a0<\/span>demonstrating<\/span>\u00a0<\/span>positive<\/span>\u00a0<\/span>dynamics<\/span>\u00a0<\/span>across<\/span>\u00a0<\/span>key<\/span>\u00a0<\/span>clinical<\/span>\u00a0<\/span>parameters<\/span>.<\/span><\/span><\/p>\n

                Pain<\/span>\u00a0<\/span>Reduction<\/span> (VAS)<\/span><\/span><\/span><\/h3>\n

                At 6 months post-treatment:<\/span>\u00a0<\/span><\/p>\n

                  \n
                • mean pain score decreased from\u00a0<\/span>8 to 2<\/strong>\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
                    \n
                  • in\u00a0some\u00a0patients,\u00a0pain\u00a0was\u00a0reduced\u00a0to\u00a0<\/span>complete\u00a0resolution<\/strong>\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n

                    \"\"<\/span><\/p>\n

                    Functional<\/span>\u00a0<\/span>Improvement<\/span> (WOMAC)<\/span><\/span><\/span><\/h3>\n

                    Assessment using the WOMAC scale demonstrated significant functional improvement:<\/span>\u00a0<\/span><\/p>\n

                      \n
                    • reduction from\u00a0<\/span>80 to 20 points<\/strong>.<\/span><\/b><\/li>\n<\/ul>\n

                      \"\"<\/span><\/p>\n

                      Functional\u00a0<\/span>Outcomes<\/span><\/span><\/h3>\n

                      Additional findings included:<\/span>\u00a0<\/span><\/p>\n

                        \n
                      • increase in knee flexion range of motion by\u00a0<\/span>10%<\/strong>\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
                          \n
                        • improvement in load-bearing function by\u00a0<\/span>4%\u00a0<\/strong><\/li>\n<\/ul>\n

                          These findings indicate restoration of joint biomechanics.<\/span>\u00a0<\/span><\/p>\n

                          Outcomes<\/span>\u00a0<\/span>in<\/span>\u00a0<\/span>Nonunion<\/span>\u00a0<\/span>Cases<\/span> <\/span><\/h3>\n

                          Clinical outcomes for long bone nonunions included:<\/span>\u00a0<\/span><\/p>\n

                            \n
                          • 71.4%<\/strong>\u00a0\u2014 complete bone union\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
                              \n
                            • 28.6%<\/strong>\u00a0\u2014 formation of stable callus\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n

                              These results demonstrate the potential of MSC therapy in complex clinical scenarios.<\/span>\u00a0<\/span><\/p>\n

                              \"\"<\/span><\/p>\n

                              Safety<\/span>\u00a0<\/span>Profile<\/span><\/h3>\n
                                \n
                              • 30%<\/span><\/b>\u00a0of patients experienced mild synovitis or discomfort\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
                                  \n
                                • symptoms resolved spontaneously within\u00a0<\/span>1\u20132 days<\/span><\/b>\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
                                    \n
                                  • no pharmacological intervention was required\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n

                                    Clinical<\/span>\u00a0<\/span>Significanse<\/span><\/span><\/h3>\n

                                    The obtained results suggest that MSC therapy, as part of a multimodal treatment approach, may:<\/span>\u00a0<\/span><\/p>\n

                                      \n
                                    • reduce pain intensity\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
                                        \n
                                      • improve joint function\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
                                          \n
                                        • enhance mobility and quality of life\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
                                            \n
                                          • delay the need for surgical intervention\u00a0<\/span>\u00a0<\/span><\/li>\n<\/ul>\n

                                            Participation in ASIR 2026 confirms ReoCell\u2019s active integration into the scientific and medical community of Ukraine.<\/span>\u00a0<\/span><\/p>\n

                                            The presented data demonstrate that cell-based technologies are becoming an important tool in the management of orthopedic conditions, offering new opportunities for disease control and preservation of function.<\/span><\/span>\u00a0<\/span><\/p>\n

                                            \"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

                                            The Center for Advanced Cell Technologies ReoCell was represented at the scientific and practical conference ASIR 2026 \u201cCurrent Challenges in the Treatment of Complications of Traumatic Injuries\u201d, held on March 26\u201327 in Lviv. More details about the conference During\u00a0the\u00a0event,\u00a0leading\u00a0specialists\u00a0of\u00a0the\u00a0ReoCell\u00a0team\u00a0presented\u00a0advanced\u00a0approaches\u00a0to\u00a0the\u00a0application\u00a0of\u00a0cell-based\u00a0technologies\u00a0in\u00a0traumatology\u00a0and\u00a0orthopedics,\u00a0as\u00a0well\u00a0as\u00a0clinical\u00a0outcomes\u00a0of\u00a0patient\u00a0treatment\u00a0using\u00a0mesenchymal\u00a0stem\u00a0cells\u00a0(MSCs). In particular, a\u00a0scientific presentation was delivered by the Medical Director of\u00a0ReoCell\u00a0Clinic, orthopedic surgeon and traumatologist, PhD\u00a0Dmytro\u00a0Horban, […]<\/p>\n","protected":false},"author":3,"featured_media":897,"comment_status":"closed","ping_status":"closed","sticky":true,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"post-type":[37],"post-whom":[38,40],"class_list":["post-879","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bez-kategoriyi","post-type-news-en","post-whom-doctors","post-whom-partners"],"acf":[],"yoast_head":"\nClinical Outcomes of Stem Cell Therapy in Traumatology and Orthopedics - Reocell<\/title>\n<meta name=\"description\" content=\"Leading specialists of ReoCell presented advanced approaches to cell therapy and clinical outcomes of mesenchymal stem cell (MSC) treatment in patients with orthopedic conditions at ASIR 2026 in Lviv.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Outcomes of Stem Cell Therapy in Traumatology and Orthopedics - Reocell\" \/>\n<meta property=\"og:description\" content=\"Leading specialists of ReoCell presented advanced approaches to cell therapy and clinical outcomes of mesenchymal stem cell (MSC) treatment in patients with orthopedic conditions at ASIR 2026 in Lviv.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/\" \/>\n<meta property=\"og:site_name\" content=\"Reocell\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-02T13:21:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-02T15:12:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/reocell.com\/wp-content\/uploads\/2026\/04\/reocell-na-asir-2026.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"585\" \/>\n\t<meta property=\"og:image:height\" content=\"357\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Administrator\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Administrator\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\\\/\"},\"author\":{\"name\":\"Administrator\",\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/#\\\/schema\\\/person\\\/4f46fb46a6c67e70f28bf45759a66d5d\"},\"headline\":\"Clinical Outcomes of Stem Cell Therapy in Traumatology and Orthopedics\",\"datePublished\":\"2026-04-02T13:21:48+00:00\",\"dateModified\":\"2026-04-02T15:12:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\\\/\"},\"wordCount\":497,\"image\":{\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/reocell.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/reocell-na-asir-2026.jpg\",\"articleSection\":[\"\u0411\u0435\u0437 \u043a\u0430\u0442\u0435\u0433\u043e\u0440\u0456\u0457\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\\\/\",\"url\":\"https:\\\/\\\/reocell.com\\\/en\\\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\\\/\",\"name\":\"Clinical Outcomes of Stem Cell Therapy in Traumatology and Orthopedics - Reocell\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/reocell.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/reocell-na-asir-2026.jpg\",\"datePublished\":\"2026-04-02T13:21:48+00:00\",\"dateModified\":\"2026-04-02T15:12:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/#\\\/schema\\\/person\\\/4f46fb46a6c67e70f28bf45759a66d5d\"},\"description\":\"Leading specialists of ReoCell presented advanced approaches to cell therapy and clinical outcomes of mesenchymal stem cell (MSC) treatment in patients with orthopedic conditions at ASIR 2026 in Lviv.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/reocell.com\\\/en\\\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/reocell.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/reocell-na-asir-2026.jpg\",\"contentUrl\":\"https:\\\/\\\/reocell.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/reocell-na-asir-2026.jpg\",\"width\":585,\"height\":357},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/reocell.com\\\/en\\\/\",\"name\":\"Reocell\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/reocell.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/reocell.com\\\/en\\\/#\\\/schema\\\/person\\\/4f46fb46a6c67e70f28bf45759a66d5d\",\"name\":\"Administrator\",\"url\":\"https:\\\/\\\/reocell.com\\\/en\\\/author\\\/administrator\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Outcomes of Stem Cell Therapy in Traumatology and Orthopedics - Reocell","description":"Leading specialists of ReoCell presented advanced approaches to cell therapy and clinical outcomes of mesenchymal stem cell (MSC) treatment in patients with orthopedic conditions at ASIR 2026 in Lviv.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Outcomes of Stem Cell Therapy in Traumatology and Orthopedics - Reocell","og_description":"Leading specialists of ReoCell presented advanced approaches to cell therapy and clinical outcomes of mesenchymal stem cell (MSC) treatment in patients with orthopedic conditions at ASIR 2026 in Lviv.","og_url":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/","og_site_name":"Reocell","article_published_time":"2026-04-02T13:21:48+00:00","article_modified_time":"2026-04-02T15:12:19+00:00","og_image":[{"width":585,"height":357,"url":"https:\/\/reocell.com\/wp-content\/uploads\/2026\/04\/reocell-na-asir-2026.jpg","type":"image\/jpeg"}],"author":"Administrator","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Administrator","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/#article","isPartOf":{"@id":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/"},"author":{"name":"Administrator","@id":"https:\/\/reocell.com\/en\/#\/schema\/person\/4f46fb46a6c67e70f28bf45759a66d5d"},"headline":"Clinical Outcomes of Stem Cell Therapy in Traumatology and Orthopedics","datePublished":"2026-04-02T13:21:48+00:00","dateModified":"2026-04-02T15:12:19+00:00","mainEntityOfPage":{"@id":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/"},"wordCount":497,"image":{"@id":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/#primaryimage"},"thumbnailUrl":"https:\/\/reocell.com\/wp-content\/uploads\/2026\/04\/reocell-na-asir-2026.jpg","articleSection":["\u0411\u0435\u0437 \u043a\u0430\u0442\u0435\u0433\u043e\u0440\u0456\u0457"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/","url":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/","name":"Clinical Outcomes of Stem Cell Therapy in Traumatology and Orthopedics - Reocell","isPartOf":{"@id":"https:\/\/reocell.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/#primaryimage"},"image":{"@id":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/#primaryimage"},"thumbnailUrl":"https:\/\/reocell.com\/wp-content\/uploads\/2026\/04\/reocell-na-asir-2026.jpg","datePublished":"2026-04-02T13:21:48+00:00","dateModified":"2026-04-02T15:12:19+00:00","author":{"@id":"https:\/\/reocell.com\/en\/#\/schema\/person\/4f46fb46a6c67e70f28bf45759a66d5d"},"description":"Leading specialists of ReoCell presented advanced approaches to cell therapy and clinical outcomes of mesenchymal stem cell (MSC) treatment in patients with orthopedic conditions at ASIR 2026 in Lviv.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/reocell.com\/en\/czentr-suchasnyh-klitynnyh-tehnologij-reocell-na-asir-2026-klinichni-rezultaty-zastosuvannya-stovburovyh-klityn-u-travmatologiyi-ta-ortopediyi\/#primaryimage","url":"https:\/\/reocell.com\/wp-content\/uploads\/2026\/04\/reocell-na-asir-2026.jpg","contentUrl":"https:\/\/reocell.com\/wp-content\/uploads\/2026\/04\/reocell-na-asir-2026.jpg","width":585,"height":357},{"@type":"WebSite","@id":"https:\/\/reocell.com\/en\/#website","url":"https:\/\/reocell.com\/en\/","name":"Reocell","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/reocell.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/reocell.com\/en\/#\/schema\/person\/4f46fb46a6c67e70f28bf45759a66d5d","name":"Administrator","url":"https:\/\/reocell.com\/en\/author\/administrator\/"}]}},"_links":{"self":[{"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/posts\/879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/comments?post=879"}],"version-history":[{"count":0,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/posts\/879\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/media\/897"}],"wp:attachment":[{"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/media?parent=879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/categories?post=879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/tags?post=879"},{"taxonomy":"post-type","embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/post-type?post=879"},{"taxonomy":"post-whom","embeddable":true,"href":"https:\/\/reocell.com\/en\/wp-json\/wp\/v2\/post-whom?post=879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}